StockTraderJack
Alejandreaux

[TimAlerts] $AEMD +60% p/m, news. Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. FDA https://finance.yahoo.com/news/aethlon-medicals-cancer-therapy-receives-122100899.html San Diego, Nov. 27, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD). The Aethlon Hemopurifier is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and life-threatening viruses.

Page
of 1